Gabi Niedermann

[Gabi Niedermann @GabiNiedermann]

Extremely happy to hear that our former PhD student @RenLuo_RAD has been awarded with the 35under35 of the Chinese Society of Clinical Oncology 2024!!

[Ren Luo, MD PhD @RenLuo_RAD]

Happy to get 35under35 of Chinese Society of Clinical Oncology 2024!

[Ren Luo, MD PhD @RenLuo_RAD]

Hope experts can advise me about combining SBRT, low-dose RT, and anti-PD1 in treating bulky tumors #WCLC2023. This is not lattice RT as only one SBRT vertex is delivered but surprisingly tumor regression was observed in some patients with multiple line failure.